Industry

Galux

An AI protein-design biotech combining machine learning with physical principles to engineer de novo antibodies and other therapeutic proteins.

Location: Seoul, South Korea
Website
1 model

Models (1)

T-SCAPE

Seoul National University / Galux

Released May 15, 2025

T-cell epitope immunogenicity prediction that fuses MHC presentation, TCR binding, and activation data via adversarial multi-domain pretraining.

Protein